PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 24, 2005European Heart Journal292 citationsOpen Access

Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study

View Full Paper
BJB. Delia Johnson

Structured PICO

Does persistent chest pain predict adverse cardiovascular events in women undergoing coronary angiography for suspected myocardial ischaemia without obstructive CAD?

P
Population
673 women undergoing coronary angiography for suspected myocardial ischaemia with at least 1 year of follow-up, median age 58 years, 20% racial minorities, 39% with obstructive CAD.
I
Intervention
Persistent chest pain (PChP), defined as self-reported continuing chest pain after 1 year of follow-up.
C
Comparator
No persistent chest pain (without PChP) after 1 year.
O
Outcome
Composite cardiovascular events (including non-fatal myocardial infarctions, strokes, congestive heart failure, and cardiovascular deaths) occurring after the first year, recorded for a median of 5.2 years.composite

Persistent chest pain in women without obstructive coronary artery disease is a significant predictor of adverse cardiovascular outcomes, challenging the assumption that this population is universally at low risk.

Abstract

AIMS: Women with chest pain but without obstructive coronary artery disease (CAD) are considered at low risk for cardiovascular (CV) events, but half continue to experience debilitating chest pain over many years. This study compared CV outcomes in women with persistent chest pain (PChP) vs. those without PChP. METHODS AND RESULTS: We studied 673 Women's Ischaemia Syndrome Evaluation (WISE) participants with chest pain undergoing coronary angiography for suspected myocardial ischaemia and at least 1 year of follow-up. PChP was defined as self-reported continuing chest pain after 1 year. Events occurring after that year were recorded for a median of 5.2 years. We compared CV event rates for women with and without PChP in subgroups with and without obstructive CAD. The median age was 58 years, 20% were racial minorities, 45% had PChP, 39% had obstructive CAD. Among women without CAD, those with PChP had more than twice the rate of composite CV events (P = 0.03), that included non-fatal myocardial infarctions (P = 0.11), strokes (P = 0.03), congestive heart failure (P = 0.38), and CV deaths (P = 0.73), compared with those without PChP. In women with CAD, there was no difference in composite CV events in those with and without PChP (P = 0.72). CONCLUSION: Among women undergoing coronary angiography for suspected myocardial ischaemia, PChP in women with no obstructive CAD predicted adverse CV outcomes. Such women might benefit from additional evaluation and aggressive risk factor modification therapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

B. Delia Johnson (2005) studied this question.

synapsesocial.com/papers/6a0f248914089a5783bdc0e6https://doi.org/10.1093/eurheartj/ehl040
Ask AI
Helpful
Bookmark
Share
View Full Paper